Antiplasmodial thiostrepton derivatives: proteasome inhibitors with a dual mode of action.
暂无分享,去创建一个
M. Kirschner | S. Baumann | B. Ellinger | G. Pradel | S. Schoof | Marco Potowski | Y. Najajreh | M. N. Aminake | Hans‐Dieter Arndt
[1] H. Arndt,et al. D-cysteine occurrence in thiostrepton may not necessitate an epimerase. , 2009, Chemical communications.
[2] P. Alonso,et al. New medicines to improve control and contribute to the eradication of malaria. , 2009, Nature reviews. Drug discovery.
[3] H. Arndt,et al. Thiopeptide antibiotic biosynthesis. , 2009, Angewandte Chemie.
[4] A. Gartel,et al. FoxM1 Is a General Target for Proteasome Inhibitors , 2009, PloS one.
[5] H. Overkleeft,et al. Chemical Tools To Study the Proteasome , 2009 .
[6] H. Arndt,et al. Zur Biosynthese von Thiopeptidantibiotika , 2009 .
[7] R. Dohmen,et al. Catalytic mechanism and assembly of the proteasome. , 2009, Chemical reviews.
[8] S. Baumann,et al. A Fluorescent Probe for the 70 S‐Ribosomal GTPase‐Associated Center , 2009, Chembiochem : a European journal of chemical biology.
[9] B. Mordmüller,et al. Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon , 2008, Malaria Journal.
[10] B. Moore,et al. Advances in and applications of proteasome inhibitors. , 2008, Current opinion in chemical biology.
[11] A. Gartel,et al. Novel anticancer compounds induce apoptosis in melanoma cells , 2008, Cell cycle.
[12] P. Rosenthal,et al. Apicoplast translation, transcription and genome replication: targets for antimalarial antibiotics. , 2008, Trends in parasitology.
[13] C. Crews,et al. Proteasome inhibition by fellutamide B induces nerve growth factor synthesis. , 2008, Chemistry & biology.
[14] Frank Schluenzen,et al. Translational regulation via L11: molecular switches on the ribosome turned on and off by thiostrepton and micrococcin. , 2008, Molecular cell.
[15] S. Baumann,et al. Mapping the binding site of thiopeptide antibiotics by proximity-induced covalent capture. , 2008, Journal of the American Chemical Society.
[16] D. Kuhn,et al. Proteasome Inhibitors in Cancer Therapy: Lessons from the First Decade , 2008, Clinical Cancer Research.
[17] N. Doudican,et al. Inhibition of mitochondrial protein translation sensitizes melanoma cells to arsenic trioxide cytotoxicity via a reactive oxygen species dependent mechanism , 2008, Cancer Chemotherapy and Pharmacology.
[18] K. El Bissati,et al. Antimalarial activity of the anticancer and proteasome inhibitor bortezomib and its analog ZL3B , 2007, BMC clinical pharmacology.
[19] Rachael A. Hughes,et al. Von Aminosäuren zu Heteroarenen – Thiopeptid-Antibiotika als heterocyclische Peptide aus der Natur† , 2007 .
[20] C. Moody,et al. From amino acids to heteroaromatics--thiopeptide antibiotics, nature's heterocyclic peptides. , 2007, Angewandte Chemie.
[21] T. Owa,et al. Splicing factor SF3b as a target of the antitumor natural product pladienolide , 2007, Nature Chemical Biology.
[22] M. Schlitzer,et al. Malaria Chemotherapeutics Part I: History of Antimalarial Drug Development, Currently Used Therapeutics, and Drugs in Clinical Development , 2007, ChemMedChem.
[23] H. Overkleeft,et al. A cell-permeable inhibitor and activity-based probe for the caspase-like activity of the proteasome. , 2007, Bioorganic & medicinal chemistry letters.
[24] G. McFadden,et al. The effects of anti-bacterials on the malaria parasite Plasmodium falciparum. , 2007, Molecular and biochemical parasitology.
[25] M. Groll,et al. 20S proteasome and its inhibitors: crystallographic knowledge for drug development. , 2007, Chemical reviews.
[26] H. Schwalbe,et al. L11 domain rearrangement upon binding to RNA and thiostrepton studied by NMR spectroscopy , 2006, Nucleic acids research.
[27] C. Gille,et al. Plasmodia express two threonine-peptidase complexes during asexual development. , 2006, Molecular and biochemical parasitology.
[28] A. Goldberg,et al. Importance of the Different Proteolytic Sites of the Proteasome and the Efficacy of Inhibitors Varies with the Protein Substrate* , 2006, Journal of Biological Chemistry.
[29] M. K. Harper,et al. A Central Strategy for Converting Natural Products into Fluorescent Probes , 2006, Chembiochem : a European journal of chemical biology.
[30] Tsutomu Suzuki,et al. Antibiotic susceptibility of mammalian mitochondrial translation , 2005, FEBS letters.
[31] M. Ghadiri,et al. Discovery of a biologically active thiostrepton fragment. , 2005, Journal of the American Chemical Society.
[32] Sushma Chaubey,et al. The apicoplast of Plasmodium falciparum is translationally active , 2005, Molecular microbiology.
[33] V. Heussler,et al. The proteasome inhibitor MLN-273 blocks exoerythrocytic and erythrocytic development of Plasmodium parasites , 2005, Parasitology.
[34] H. Ueda,et al. Suppressive effect of antibiotic siomycin on antibody production. , 2004, The Journal of antibiotics.
[35] Christopher J. Tonkin,et al. Tropical infectious diseases: Metabolic maps and functions of the Plasmodium falciparum apicoplast , 2004, Nature Reviews Microbiology.
[36] A. Goldberg,et al. The Caspase-like Sites of Proteasomes, Their Substrate Specificity, New Inhibitors and Substrates, and Allosteric Interactions with the Trypsin-like Sites* , 2003, Journal of Biological Chemistry.
[37] T. W. O'brien. Properties of Human Mitochondrial Ribosomes , 2003, IUBMB life.
[38] C. Crews,et al. Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro. , 2003, The Journal of clinical investigation.
[39] R. Tsien,et al. Creating new fluorescent probes for cell biology , 2002, Nature Reviews Molecular Cell Biology.
[40] K. Lindsten,et al. Lack of proteasome active site allostery as revealed by subunit-specific inhibitors. , 2001, Molecular cell.
[41] F. Tortella,et al. Proteasome inhibitor PS519 reduces infarction and attenuates leukocyte infiltration in a rat model of focal cerebral ischemia. , 2000, Stroke.
[42] T. McCutchan,et al. Effects of interruption of apicoplast function on malaria infection, development, and transmission. , 2000, Molecular and biochemical parasitology.
[43] C. Crews,et al. Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[44] C. Crews,et al. Eponemycin exerts its antitumor effect through the inhibition of proteasome function. , 1999, Cancer research.
[45] Satoshi Omura,et al. Proteasome Inhibitors Block Development ofPlasmodium spp , 1998, Antimicrobial Agents and Chemotherapy.
[46] D. Draper,et al. Interaction of thiostrepton with an RNA fragment derived from the plastid-encoded ribosomal RNA of the malaria parasite. , 1997, RNA.
[47] M. Strath,et al. Thiostrepton binds to malarial plastid rRNA , 1997, FEBS letters.
[48] T. McCutchan,et al. Inhibition of Plasmodium falciparum Protein Synthesis , 1997, The Journal of Biological Chemistry.
[49] D. Roos,et al. In vitro assays elucidate peculiar kinetics of clindamycin action against Toxoplasma gondii , 1995, Antimicrobial agents and chemotherapy.
[50] R. Piper,et al. Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. , 1993, The American journal of tropical medicine and hygiene.
[51] M. Makler,et al. Measurement of the lactate dehydrogenase activity of Plasmodium falciparum as an assessment of parasitemia. , 1993, The American journal of tropical medicine and hygiene.
[52] J. Jensen,et al. Oxygen- and time-dependent effects of antibiotics and selected mitochondrial inhibitors on Plasmodium falciparum in culture , 1985, Antimicrobial Agents and Chemotherapy.
[53] E. Wulf,et al. Fluorescent phallotoxin, a tool for the visualization of cellular actin. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[54] D. Hodgkin,et al. The Structure of Thiostrepton , 1970, Nature.
[55] M. Finland,et al. In vitro observations on A-8506 (bryamycin). , 1958, Antibiotics & chemotherapy.
[56] R. Wilson,et al. The plastid of Plasmodium spp.: a target for inhibitors. , 2005, Current topics in microbiology and immunology.
[57] J. Adams. The proteasome: a suitable antineoplastic target , 2004, Nature Reviews Cancer.
[58] W. Baumeister,et al. The 26S proteasome: a molecular machine designed for controlled proteolysis. , 1999, Annual review of biochemistry.
[59] K Tanaka,et al. Structure and functions of the 20S and 26S proteasomes. , 1996, Annual review of biochemistry.